Posted In: Dermatology
Within the broad scope of the general medical field, countless dedicated professionals save lives, develop cures for otherwise fatal diseases, increase the quality of life for affected individuals, and perform preventative care to ensure that individuals can lead healthy, happy, and well-rounded lives. In their respective roles, these highly trained medical professionals spearhead innovative thought, dedicate their time and energy toward the betterment of society, partake in boundary-pushing research, and advance their fields with passion, vigor, and dedication. For many, however, boundaries and limitations can exist as a result of practicing under a large-scale conglomerate, or being reliant on corporate funding for research dedications. For others, perhaps they are unable to specialize in a particular niche due to demand issues, funding, or other factors outside of their control.
Discussing physical pain is difficult for the families and friends of individuals who experience chronic pain, their medical providers, and those responsible for someone’s direct care. Apart from direct care, there are several other communities who approach this topic with varying insights: the general medical community, the holistic community, and even the local and federal government. With so many opinions, facts, research statistics, reviews, and communal interactions, there is a lot of information for those who seek to minimize chronic pain.
Dr. Mark Holterman received training for running his own business while growing up on a farm in Wisconsin where he also helped his father run his construction business. He was exposed to the challenges that business owners face at that time, but he also was privileged to enjoy the rewards. He cherishes his days on the farm, but he had other dreams, so when he was accepted at Yale University, he gladly left Wisconsin. Dr. Mark Holterman graduated from Yale with honors.
Medical technology and practices have been advancing at an incredible rate over the past few decades, and one of the premier breakthroughs in the space is CRISPR. At a high level, CRISPR is a process that allows editing DNA sequences and gene function, which opens up a world of possibilities when it comes to developing new medicine and treatments. However, CRISPR as we know it today is not a perfectly precise tool, as it requires the rewrite of entire subsections of DNA or a genome. A new breakthrough in a joint study by Harvard and MIT has resulted in a new process called base editing, which gives researchers the ability to edit minute portions of DNA. In other words, if a single word needed changing in a paragraph, CRISPR would require rewriting the entire paragraph with one word changed while base editing would allow changing the specific word itself.
Amicus Therapeutics recently announced that they are seeking FDA approval for a new drug therapy designed to provide effective treatment for the rare condition called Fabry disease. What is Fabry disease and what does this rare condition entail? How does this new medication help control bothersome symptoms associated with Fabry disease? What is Amicus Therapeutics and what do they specialize in? The following information has been designed to answer these important questions.